Pheniramine 22.75mg/ml Injection Franchise in Ahmedabad

Antihistamine Therapy Supplier in Mumbai

Phenimin Injection Distributor in Delhi

Allergy & Hypersensitivity Injection Franchise Opportunity in Bangalore

Injectable Antihistamine Stockist in Hyderabad
Pheniramine 22.75mg/ml Export & Manufacturing in Chandigarh

Home/Products /pheniramine-22-75mg-ml-injection

About the Product

Description


Phenimin Injection contains Pheniramine 22.75mg/ml, an antihistamine indicated for the management of allergic reactions, urticaria, rhinitis, conjunctivitis, and other hypersensitivity conditions. It helps in relieving itching, redness, and swelling associated with allergic responses.

Pheniramine works by blocking H1 histamine receptors, thereby preventing histamine-mediated allergic symptoms and providing rapid relief. Its injectable formulation allows precise dosing and fast onset of action for acute conditions.

For distributors and healthcare suppliers, Phenimin Injection is a high-demand antihistamine therapy product, widely used in hospitals, clinics, emergency care, and allergy specialty centers. The prevalence of allergic disorders ensures consistent market demand throughout the year.

Adding Phenimin Injection to your allergy and hypersensitivity therapy segment creates strong opportunities in pharmacies, hospitals, clinics, export markets, and third-party manufacturing. Its fast-acting injectable formulation, prescriber trust, and broad clinical use make it a valuable addition to pharmaceutical distribution portfolios.

Common side effects may include drowsiness, dizziness, dry mouth, or mild gastrointestinal discomfort. Rare but serious side effects include severe hypersensitivity reactions, hypotension, or respiratory depression. Immediate medical attention is required if severe symptoms occur.

Phenimin Injection is indicated for the treatment of allergic conditions such as urticaria, angioedema, hay fever, drug allergies, and anaphylactic reactions (as part of combination therapy), as prescribed by a healthcare professional.

Phenimin Injection should be administered only under medical supervision. Patients with a history of glaucoma, urinary retention, or cardiovascular disease should inform their doctor before use. Caution is advised when operating machinery or driving due to possible sedation.

Store Phenimin Injection in a cool, dry place away from direct sunlight. Keep out of reach of children and do not use the injection beyond the expiry date printed on the vial.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Pheniramine Maleate 22.75mg/ml Injection in the PCD pharma franchise market?

Pheniramine Maleate 22.75mg/ml Injection has steady demand in the allergy care, emergency medicine, hospital care, and general healthcare segment, making it a valuable product for medical distributors, wholesalers, and pharma franchise partners focusing on injectable and emergency care portfolios.

Why should medical distributors include Pheniramine Maleate 22.75mg/ml Injection in their product range?

Medical distributors and agencies can benefit from consistent demand for allergic reaction management under medical supervision. Pheniramine Maleate 22.75mg/ml is an antihistamine used to help manage allergic conditions and hypersensitivity reactions Commonly utilized in the treatment of allergic reactions, urticaria (hives), itching, drug-induced allergies, insect bite reactions, and other allergic conditions as advised by healthcare professionals Injectable formulation allows rapid administration in hospital and emergency care settings when required Frequently used in emergency departments, hospitals, clinics, and healthcare institutions Often included in emergency and critical care medication inventories Widely used by general physicians, emergency care specialists, and healthcare professionals This strengthens a comprehensive allergy care and hospital care portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this product?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Pheniramine Maleate 22.75mg/ml Injection with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from steady institutional demand, hospital procurement opportunities, reliable supply chain support, repeat orders, and attractive margins in the injectable segment.

How can I become a distributor or franchise partner for this product?

Interested distributors, stockists, and wholesalers can partner with Cafoli LifeCare Pvt Ltd to access lucrative PCD pharma franchise opportunities across India. With exclusive monopoly rights, extensive promotional support, high-quality pharmaceutical products, attractive business margins, and dependable logistics support, Cafoli LifeCare Pvt Ltd helps franchise partners build a successful and profitable pharmaceutical business.